Delivery Order SPE2DB24D8002-SPE2DB25FJMYX

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,272.41 fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of October 19, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $5,011.42 firm fixed-price contract has a period of performance through November 8, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a $2,578.55 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. This delivery order contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,693.07, is for the procurement of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The delivery order does not have a set-aside designation and supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The order, valued at $4,062.92, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,155.04 contract is for the supply of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Dakota Drug, Inc. has a long history of serving as a prime contractor to the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,368.53 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a performance period ending on March 14, 2024 and does not include a set-aside designation. Through this and previous awards, Dakota Drug has provided a wide range of medical supplies and...
This federal contract award, valued at $5,108.06, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order for the supply of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical, medical supplies, and healthcare equipment. The company holds a significant single-award Indefinite...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMYX
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This delivery order was placed under Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. The contract does not have a set-aside designation, indicating Dakota Drug's competitive position in the federal marketplace. As a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, Dakota Drug, Inc. has demonstrated its capability to efficiently deliver critical medical items to various defense healthcare facilities.

Generated 5/21/25, 9:55 AM